CTOs on the Move

Sterilmed

www.sterilmed.com

 
The merged expertise of SterilMed and The Scope Exchange in the repair and reprocessing of medical devices provides the opportunity to utilize a comprehensive single-source supplier. The merged expertise combined with SterilMed's broad market presence
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.sterilmed.com
  • 11400 73rd Ave N Ste 100
    Maple Grove, MN USA 55369
  • Phone: 763.488.3400

Executives

Name Title Contact Details

Similar Companies

Belco Packaging Systems

Belco Packaging Systems is a Monrovia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Dental Partners, Inc.

American Dental Partners, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

VisCardia

VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.

Coloplast

Coloplast is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Transgenomic

Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.  Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.